This edition of the American Journal of Rhinology and Allergy (AJRA) maintains the tradition of high-quality basic science and clinical research within the field of allergy and rhinology. We continue to see rapid translation of basic science studies into changes in our clinical practices. This issue highlights the exciting advancements in our understanding and treatment of the diverse array of pathologies that affect the nose and paranasal sinuses.
The current issue includes a number of articles exploring techniques to optimize surgical outcomes in patients undergoing sinonasal surgery. The first article by Ceylan et al. 1 investigates a novel plant-based molecule, halofuginone, and its anti-inflammatory effect on mucosal wound healing in rats. In a "How I Do It" format article, Lou describes the use of microwave ablation for the treatment of benign sinonasal lesions in the outpatient setting. 2 A review article by Loftus et al. 3 details the safety and success of the endoscopic modified medial maxillectomy for recalcitrant maxillary sinusitis. Lastly, to cover the full gamut of sinonasal surgery, Jolly et al. 4 describes a novel technique using a polydioxanone plate (PDS) wrap to prevent brain herniation in the setting of large anterior cranial base defects after endoscopic skull base surgery.
The signaling pathways and gene expression patterns for inflammatory diseases of the nose are among the most exciting topics in our field and remains a focus of AJRA. Zhong et al. 5 highlight the inhibitory function of T-box 1 (TBX1) on the inflammatory process of chronic rhinosinusitis (CRS), while Yan et al. 6 describe the role of microRNA 146a to downregulate the expression of mucins which are important components of secreted mucus. Finally, a study by Peng et al. 7 investigates aberrant cilia-related gene expression in patients with allergic rhinitis. Ultimately, how these expression patterns translate into different endotypes is at the forefront of many research initiatives. In a study of eosinophil counts on histopathologic analysis, Brescia et al. 8 studied patients with CRS with nasal polyps (CRSwNP) to better understand pathophysiology-based endotypes and identified patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (NERD) to have the highest eosinophilic reaction on histopathologic analysis.
Genetic diseases, such as cystic fibrosis (CF), remain a challenge yet over the last several decades there have been dramatic improvements in patient outcomes. In this issue of AJRA, 2 articles focus on this condition. Di Lullo et al. 9 identified that while many patients with CF report being normosmic, the vast majority of these patients suffer from a decreased sense of smell. Pulmonary function is another critical variable to consider in patients with CF and a systematic review by Zhao et al. 10 explored the influence of glutathione compared to placebo on pulmonary function.
Novel treatment regimens continue to be studied for CRS. While steroids, either systemic or topical, remain a workhorse for the treatment of patients with CRSwNP, adjunctive therapies are being constantly evaluated. A prospective study by Attia 11 identified a delayed recurrence of nasal polyps in patients treated with 3 g/day of an omega-3 fatty acid in combination with budesonide rinses as compared to budesonide rinses alone. An in vitro study by Papadopoulou et al. 12 of a novel synthetic honey-equivalent product demonstrated marked antimicrobial activity against Staphylococcus aureus bacterial biofilms. The quality of life in patients who suffer from sinonasal conditions is significant. This is highlighted in a manuscript by Robles-Figueroa et al. 13 who demonstrated an independent association of allergic rhinitis with loss of energy and concentration difficulty. In addition, allergic rhinitis may also contribute to lingual tonsil hypertrophy as suggested by Coban et al. 14 Yet, establishing a diagnosis of allergic rhinitis may be elusive. This is underscored by Ishida et al. 15 who identified that many patients undergoing surgery for CRS were identified to have elevated nasal antibodies to house dust mites and Japanese cedar pollen despite negative blood and skin allergy tests. The difficulty of identifying the underlying pathogenesis of CRS can also be perplexing. Li et al. 16 studied the prevalence of immunologic disease in pediatric rhinosinusitis to identify the necessary high yield testing for an immunologic evaluation.
Finally, this issue of AJRA tackles 2 of the more challenging diseases in our specialty: epistaxis and empty nose syndrome (ENS). Bui et al. 17 evaluated 100 consecutive patients presenting to the emergency department for epistaxis to identify risk factors for bleeding and develop a consult algorithm to assist in the appropriate allocation of resources. A systematic review by Gill et al. 18 discusses the benefits of the Empty Nose Syndrome 6 Questionnaire (ENS6Q) and the in-office cotton test as adjuncts to ascertain the diagnosis of ENS. However, as the authors point out, there is a high incidence of psychological dysfunction in this patient population which further complicates successful treatment of these patients.
We hope you enjoy this edition of AJRA that showcases high-quality articles encompassing all aspects of allergy and rhinology. The AJRA is at the forefront of providing the most up-to-date basic science, translational, and clinical research in our specialties. I would like to thank the editorial board and reviewers for AJRA who work hard to publish meaningful and original research that benefits all its readers. This truly is an exciting time to be in the field of allergy and rhinology!
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